Alfresa Holdings Corp represents strong values and a dedicated corporate philosophy. The company prioritizes customer satisfaction, aiming to provide high-quality and innovative healthcare products and services. Alfresa Holdings Corp firmly believes in the importance of contributing to society through its business activities. By constantly striving for growth and professional development, the company aims to create sustainable value for shareholders. With a focus on integrity, transparency, and trust, Alfresa Holdings Corp aims to be a reliable partner in the healthcare industry, making a positive impact on the lives of many.

Alfresa Holdings Corp primarily operates in Japan.

Alfresa Holdings Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leading player in the pharmaceutical distribution industry in Japan. One of its major achievements is the expansion of its business operations, both domestically and internationally, through strategic acquisitions and partnerships. Alfresa Holdings Corp has also gained recognition for its commitment to innovation and technological advancements in the healthcare sector. Additionally, the company has consistently focused on enhancing its product offerings and strengthening its supply chain management capabilities. These milestones have contributed to Alfresa Holdings Corp's continuous growth and establishment of a strong presence in the industry.

Alfresa Holdings Corp, a prominent Japanese company, has a rich history and background. Established in 2005, it was formed through a merger between Yakuji Nippo Ltd. and JW Pharmaceuticals Co., Ltd. Alfresa Holdings Corp primarily operates in the healthcare industry and offers a wide range of services including wholesale distribution of pharmaceuticals and medical supplies, retail pharmacy operations, and the provision of clinical research support. With its commitment to ensuring healthy lives and quality healthcare, Alfresa Holdings Corp has become a key player in the Japanese market. Its dedication to innovation and customer satisfaction has contributed significantly to its growth and success.

Some of the main competitors of Alfresa Holdings Corp in the market include Cardinal Health Inc., McKesson Corporation, and AmerisourceBergen Corporation.

Alfresa Holdings Corp is primarily active in the pharmaceutical industry.

The business model of Alfresa Holdings Corp revolves around the pharmaceutical distribution industry. As a leading healthcare company in Japan, Alfresa provides a wide range of services, including the wholesale distribution of pharmaceutical products, medical equipment, and healthcare products to hospitals, clinics, and pharmacies. By efficiently delivering quality products and utilizing advanced logistics systems, Alfresa strives to contribute to the improvement of medical care in Japan. With its extensive network and strategic partnerships, the company aims to enhance the pharmaceutical supply chain and support healthcare professionals in providing reliable and accessible healthcare solutions to patients across the country.

KGV kan för närvarande inte beräknas för Alfresa Holdings.

KUV kan för närvarande inte beräknas för Alfresa Holdings.

AlleAktien Qualitätsscore för Alfresa Holdings är 5/10.

Omsättningen kan för närvarande inte beräknas för Alfresa Holdings.

Vinsten kan för närvarande inte beräknas för Alfresa Holdings.

Alfresa Holdings Corp is a Japanese company that operates in the healthcare sector and offers a wide range of products and services. The company's business model is based on providing pharmaceutical products, medical devices, and services to the healthcare industry. The company is divided into several business segments, including Alfresa Pharma Corporation, which focuses on the development, manufacturing, and distribution of pharmaceutical products. Alfresa Pharma offers a wide range of products, including generics, complex generics, biosimilars, and biological drugs. The company works closely with manufacturers in Japan and worldwide to deliver high-quality products. Another important business segment of Alfresa Holdings Corp is Alfresa Medical Corporation, which focuses on the supply of medical products and devices. The company offers a wide range of products, from surgical instruments to medical devices and diagnostics. Additionally, Alfresa Medical Corporation also provides logistics services to the healthcare industry. The company also offers a wide range of services to the healthcare industry, including professional training, consulting services, and IT solutions. Alfresa Holdings Corp is committed to providing its customers with high-quality products and services and works closely with them to identify specific needs and requirements and provide tailored solutions. Alfresa Holdings Corp has a strong focus on innovation and invests in research and development to improve products and services and bring new products to the market. The company also collaborates closely with academic institutions and research institutes to identify collaborative initiatives to promote innovation and technology development. Alfresa Holdings Corp is a leading company in healthcare in Japan and is committed to improving the healthcare system in the country. The company is also actively involved in business development in other countries and works closely with partners worldwide to distribute its products and services. Overall, Alfresa Holdings Corp's business model is focused on providing high-quality products and services to the healthcare industry. The company has a wide range of products and services and actively works on innovation and technology development to better meet the needs of its customers. With a strong focus on quality and customer satisfaction, Alfresa Holdings Corp continues to set new standards in healthcare.

Alfresa Holdings delar ut en utdelning på 0 JPY fördelad över utbetalningar per år.

Utbytet kan för närvarande inte beräknas för Alfresa Holdings eller så distribuerar bolaget inget utbyte.

ISIN för Alfresa Holdings är JP3126340003.

WKN för Alfresa Holdings är 912620.

Ticker-symbolen för Alfresa Holdings är 2784.T.

Under de senaste 12 månaderna betalade Alfresa Holdings en utdelning på . Detta motsvarar en direktavkastning på ungefär . För de kommande 12 månaderna förväntas Alfresa Holdings betala en utdelning på 64,65 JPY.

Aktiens direktavkastning för Alfresa Holdings är för närvarande .

Alfresa Holdings betalar ut dividenden kvartalsvis. Denna distribueras under månaderna oktober, april, oktober, april.

Alfresa Holdings betalade utdelning varje år under de senaste 23 åren.

För de kommande 12 månaderna förväntas utdelningar uppgå till 64,65 JPY. Detta motsvarar en utdelningsavkastning på 2,98 %.

Alfresa Holdings tilldelas sektorn 'Hälsa'.

För att få den senaste utdelningen från Alfresa Holdings den 2024-12-01 på 31 JPY var du tvungen att ha aktien i ditt depå innan ex-dagen den 2024-09-27.

Utdelningen av den senaste dividenden skedde den 2024-12-01.

Under år 2023 delade Alfresa Holdings ut 58 JPY i form av utdelningar.

Utdelningarna från Alfresa Holdings betalas ut i JPY.